Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01542125Phase 4Completed
Phase 4, randomised, triple-blind trial in procedural pain comparing Liposomal Lidocaine group with Placebo Group (2 arms). Primary endpoint: Pain Score at 30 months. Started Sep 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01542125.